Somerville Kurt F Abbott Laboratories Transaction History

Somerville Kurt F

$578 Million
Q4 2024

A detailed history of Somerville Kurt F transactions in Abbott Laboratories stock. As of the latest transaction made, Somerville Kurt F holds 166,957 shares of ABT stock, worth $21.2 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares

166,957

Previous 165,961 0.6%

Holding current value

$21.2 Million

Previous $18.9 Million 0.2%

% of portfolio

3.27%

Previous 3.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $111,482 - $118,912	996 Added 0.6%	166,957 $18.9 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $83,758 - $98,874	-837 Reduced 0.5%	165,961 $18.9 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $95,391 - $106,480	947 Added 0.57%	166,798 $17.3 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $657 - $725	-6 Reduced -0.0%	165,851 $18.9 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $485,041 - $593,731	5,378 Added 3.35%	165,857 $18.3 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $330,820 - $396,929	3,463 Added 2.21%	160,479 $15.5 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.99 Million - $2.21 Million	-19,723 Reduced 11.16%	157,016 $17.1 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $68,770 - $80,947	710 Added 0.4%	176,739 $17.9 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $15,399 - $18,066	162 Added 0.09%	176,029 $19.3 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $15,675 - $18,148	-162 Reduced 0.09%	175,867 $17 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $2,653 - $3,207	26 Added 0.01%	176,029 $19.1 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $1.82 Million - $2.21 Million	-15,925 Reduced 8.3%	176,003 $20.8 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $268,145 - $328,328	-2,321 Reduced 1.19%	191,928 $27 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $304,015 - $336,330	-2,606 Reduced 1.32%	194,249 $22.9 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $150,116 - $176,708	-1,419 Reduced 0.72%	196,855 $22.8 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $168,266 - $198,243	-1,546 Reduced 0.77%	198,274 $23.8 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $300,825 - $327,813	-2,865 Reduced 1.41%	199,820 $21.9 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $412,838 - $501,361	-4,505 Reduced 2.17%	202,685 $22.1 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $11,332 - $14,504	-148 Reduced 0.07%	207,190 $18.9 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $160,442 - $234,610	-2,554 Reduced 1.22%	207,338 $16.4 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $342,460 - $381,238	-4,362 Reduced 2.04%	209,892 $18.2 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $487,357 - $528,446	-5,955 Reduced 2.7%	214,254 $17.9 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $820,774 - $957,270	-11,262 Reduced 4.87%	220,209 $18.5 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $536,249 - $648,325	-8,098 Reduced 3.38%	231,471 $18.5 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $46,547 - $52,731	-710 Reduced 0.3%	239,569 $17.3 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $109,336 - $131,901	1,798 Added 0.75%	240,279 $17.6 Million
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $56,361 - $62,205	-979 Reduced 0.41%	238,481 $14.5 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $428,777 - $484,784	-7,620 Reduced 3.08%	239,460 $14.4 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $64,147 - $68,676	1,195 Added 0.49%	247,080 $14.1 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $11.8 Million - $13.2 Million	245,885	245,885 $13.1 Million

Others Institutions Holding ABT

# of Institutions

3,375

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Abbott Laboratories Transaction History